RNAC Competitors & Alternatives
Compare Cartesian Therapeutics Inc. with similar stocks in the same industry
Biotechnology
RNAC
Main Stock$7.22
Tradestie Score
56
Market Cap
$266.26M
Revenue Growth
-0.9%
Analyst Upside
+366.3%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
KYTX
Kyverna Therapeutics, Inc. Common Stock
|
$6.52
|
$258.18M | - | 48 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 51 | Compare |
|
NGNE
Neurogene, Inc. Common Stock
|
$26.55
|
$256.54M | - | 42 | Compare |
|
SLN
Silence Therapeutics Plc American Depository Share
|
$10.71
|
$240.89M | - | 55 | Compare |
|
OABI
OmniAb, Inc. Common Stock
|
$5.04
|
$231.77M | - | 38 | Compare |
|
SGMT
Sagimet Biosciences Inc. Series A Common Stock
|
$9.37
|
$227.00M | - | 59 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$11.33
|
$211.22M | - | 63 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$4.41
|
$202.58M | - | 57 | Compare |
|
CBIO
Crescent Biopharma, Inc. Common Stock
|
$14.26
|
$199.71M | - | 58 | Compare |
|
FBRX
Forte Biosciences, Inc. Common Stock
|
$76.99
|
$180.53M | - | 54 | Compare |
More RNAC Analysis
Data updated: Oct 02, 2026 | Industry: Biotechnology (SIC 2834)
232 stocks in this industry